Stay updated on Subcutaneous vs Intravenous Atezolizumab in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Subcutaneous vs Intravenous Atezolizumab in NSCLC Clinical Trial page.

Latest updates to the Subcutaneous vs Intravenous Atezolizumab in NSCLC Clinical Trial page
- CheckyesterdayChange DetectedRevision tag updated from v3.6.4 to v3.6.5 in the record history. This reflects a minor metadata update to the study record.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check16 days agoChange DetectedA new revision entry, v3.6.4, was added to the study record history, replacing the previous revision v3.6.3. This indicates an update to the record's metadata in the history log.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check37 days agoChange DetectedThe history now shows a new revision entry (v3.6.3) and the previous entry (v3.6.2) is removed, updating the page's revision history to reflect a recent change.SummaryDifference0.1%

- Check44 days agoChange DetectedRevision: v3.6.2 replaces the previous v3.6.0 in the page header, indicating the current page version has been updated. This reflects maintenance of the study history page rather than substantive content changes.SummaryDifference0.1%

- Check58 days agoChange DetectedRecruitment status updated to no longer looking for participants, indicating enrollment has ceased. The record version is updated to v3.6.0, replacing the previous v3.5.5 revision.SummaryDifference0.3%

- Check66 days agoChange DetectedA new revision entry labeled v3.5.5 was added to the history, and the previous v3.5.4 entry was removed from the listing, reflecting an update to the record.SummaryDifference0.1%

Stay in the know with updates to Subcutaneous vs Intravenous Atezolizumab in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Subcutaneous vs Intravenous Atezolizumab in NSCLC Clinical Trial page.